Jake Lichterman

1.1k total citations
10 papers, 739 citations indexed

About

Jake Lichterman is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jake Lichterman has authored 10 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Jake Lichterman's work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (2 papers) and Immune cells in cancer (2 papers). Jake Lichterman is often cited by papers focused on MicroRNA in disease regulation (3 papers), RNA modifications and cancer (2 papers) and Immune cells in cancer (2 papers). Jake Lichterman collaborates with scholars based in United States, Taiwan and China. Jake Lichterman's co-authors include Sangeetha M. Reddy, Leland W.K. Chung, Edwin M. Posadas, Sajni Josson, Murali Gururajan, Yi‐Tsung Lu, Christopher L. Haga, Peng Duan, André Rogatko and Haiyen E. Zhau and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Jake Lichterman

10 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jake Lichterman United States 7 415 377 287 142 119 10 739
Lisa K. Spary United Kingdom 9 432 1.0× 302 0.8× 174 0.6× 95 0.7× 58 0.5× 13 630
Yuze Hua China 6 317 0.8× 216 0.6× 301 1.0× 125 0.9× 101 0.8× 14 670
Clotilde Costa Spain 15 367 0.9× 278 0.7× 314 1.1× 64 0.5× 146 1.2× 31 677
Anna Babayan Germany 10 437 1.1× 522 1.4× 270 0.9× 108 0.8× 87 0.7× 13 739
Qingyang Lei China 8 333 0.8× 225 0.6× 441 1.5× 143 1.0× 77 0.6× 15 852
Danielle Murphy United States 5 549 1.3× 308 0.8× 641 2.2× 132 0.9× 39 0.3× 13 935
Wenting Liao China 7 662 1.6× 461 1.2× 305 1.1× 84 0.6× 56 0.5× 9 851
Panqi Fang China 7 415 1.0× 312 0.8× 421 1.5× 99 0.7× 90 0.8× 7 811
Rekha Samuel United States 9 280 0.7× 162 0.4× 261 0.9× 67 0.5× 114 1.0× 9 706
Bianca Behrens Germany 12 208 0.5× 325 0.9× 407 1.4× 84 0.6× 116 1.0× 21 598

Countries citing papers authored by Jake Lichterman

Since Specialization
Citations

This map shows the geographic impact of Jake Lichterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Lichterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Lichterman more than expected).

Fields of papers citing papers by Jake Lichterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake Lichterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Lichterman. The network helps show where Jake Lichterman may publish in the future.

Co-authorship network of co-authors of Jake Lichterman

This figure shows the co-authorship network connecting the top 25 collaborators of Jake Lichterman. A scholar is included among the top collaborators of Jake Lichterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake Lichterman. Jake Lichterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Coughlin, Laura, Nicole Poulides, Jake Lichterman, et al.. (2024). Abstract 3733: Gut microbiota-dependent bile acidtaurodeoxycholic acid, TDCAfacilitates anti-tumor immune responses by modulating cytotoxic CD8 T cell immunity. Cancer Research. 84(6_Supplement). 3733–3733. 1 indexed citations
2.
Lichterman, Jake, Laura Coughlin, Nicole Poulides, et al.. (2023). Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. Science Immunology. 8(81). eabo2003–eabo2003. 76 indexed citations
3.
Jang, Albert, Jake Lichterman, Jonathan E. Shoag, et al.. (2023). Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. Human Vaccines & Immunotherapeutics. 19(3). 2276629–2276629. 4 indexed citations
4.
Lichterman, Jake & Sangeetha M. Reddy. (2021). Mast Cells: A New Frontier for Cancer Immunotherapy. Cells. 10(6). 1270–1270. 99 indexed citations
5.
Lichterman, Jake, et al.. (2017). A novel role for 17-Β estradiol and testosterone in osteosarcoma tumorigenesis and metastasis.. Journal of Clinical Oncology. 35(15_suppl). e23012–e23012. 1 indexed citations
6.
Chen, Jie‐Fu, Hao Ho, Jake Lichterman, et al.. (2015). Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer. 121(18). 3240–3251. 92 indexed citations
7.
Josson, Sajni, Murali Gururajan, Peizhen Hu, et al.. (2014). miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer. Clinical Cancer Research. 20(17). 4636–4646. 118 indexed citations
8.
Gururajan, Murali, Sajni Josson, Gina Chia‐Yi Chu, et al.. (2014). miR-154* and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer. Clinical Cancer Research. 20(24). 6559–6569. 82 indexed citations
9.
Josson, Sajni, Murali Gururajan, Shian‐Ying Sung, et al.. (2014). Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene. 34(21). 2690–2699. 170 indexed citations
10.
Lu, Yi‐Tsung, Libo Zhao, Qinglin Shen, et al.. (2013). NanoVelcro Chip for CTC enumeration in prostate cancer patients. Methods. 64(2). 144–152. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa K. Spary Breakdown of academic impact, for papers by Yuze Hua Breakdown of academic impact, for papers by Clotilde Costa Breakdown of academic impact, for papers by Anna Babayan Breakdown of academic impact, for papers by Qingyang Lei Breakdown of academic impact, for papers by Danielle Murphy Breakdown of academic impact, for papers by Wenting Liao Breakdown of academic impact, for papers by Panqi Fang Breakdown of academic impact, for papers by Rekha Samuel Breakdown of academic impact, for papers by Bianca Behrens
Rankless by CCL
2026